{
    "clinical_study": {
        "@rank": "60316", 
        "arm_group": [
            {
                "arm_group_label": "DC086", 
                "arm_group_type": "Experimental", 
                "description": "cream"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess the the effect of the study product on itching\n      symptoms associated with xerotic dermatitis in aged population"
        }, 
        "brief_title": "Xerotic Dermatitis in Aged People", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Itching Symptoms", 
            "Xerotic Dermatitis"
        ], 
        "condition_browse": {
            "mesh_term": "Dermatitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged from 70 years\n\n          -  With xerotic dermatitis, clinically assessed ,\n\n          -  At least on the anterior part of lower and/or upper limbs,\n\n          -  Presenting itching xerotic dermatitis evolving from at least 3 weeks\n\n          -  Intensity of itching \u2265 4 on VAS (0-10) at th inclusion time\n\n          -  With MMSE score \u2265 20 dating less than 6 months\n\n          -  Affiliated to a social security system, or is a beneficiary (as applicable in the\n             national regulation)\n\n        Exclusion Criteria:\n\n          -  Criteria related to pathologies\n\n               -  Severe form of other dermatitis requiring either systemic treatment\n\n                  -- Itching xerotic dermatitis from iatrogenic origins\n\n               -  Dermatological disease other than xerotic dermatitis which could interfere with\n                  the assessment,\n\n               -  Systemic disease that may generate xerotic dermatitis and /or pruritus\n\n               -  Immunosuppression condition,\n\n               -  History of serious disease considered by the investigator hazardous for the\n                  patient or incompatible with the study.\n\n          -  Criteria related to treatment\n\n             - Use of treatment which could interfere with the evaluation of the disease or the\n             course of the disease\n\n          -  Criteria related to the population\n\n               -  Ongoing participation to another clinical trial or participation in the previous\n                  month before the inclusion\n\n               -  Patient under guardianship or trusteeship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "442", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806935", 
            "org_study_id": "2012-A01547-36"
        }, 
        "intervention": [
            {
                "arm_group_label": "DC086", 
                "intervention_name": "DC086", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "associated", 
            "aged population"
        ], 
        "lastchanged_date": "September 25, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France"
                    }, 
                    "name": "0523"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France"
                    }, 
                    "name": "0521"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cugnaux", 
                        "country": "France"
                    }, 
                    "name": "0520"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Fousseret", 
                        "country": "France"
                    }, 
                    "name": "0517"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muret", 
                        "country": "France"
                    }, 
                    "name": "0518"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muret", 
                        "country": "France"
                    }, 
                    "name": "0519"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Orens de Gameville", 
                        "country": "France"
                    }, 
                    "name": "0515"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Orens de Gameville", 
                        "country": "France"
                    }, 
                    "name": "0516"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seysses", 
                        "country": "France"
                    }, 
                    "name": "0514"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seysses", 
                        "country": "France"
                    }, 
                    "name": "0513"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seysses", 
                        "country": "France"
                    }, 
                    "name": "0512"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seysses", 
                        "country": "France"
                    }, 
                    "name": "0511"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tierce", 
                        "country": "France"
                    }, 
                    "name": "0522"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "0501"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "H\u00f4pital Purpan CHU TOULOUSE, France", 
            "last_name": "Yves Rolland", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Itching symptoms intensity change", 
            "safety_issue": "No", 
            "time_frame": "From Day 1 to 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806935"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pierre Fabre Medicament", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pierre Fabre Medical Devices", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}